School in Boston, Mass., and his collaborators. This conclusion is based on viewing how cells change while growing on "microbial evolution and growth arena (MEGA)" plates, following those cells as they spread along large plates containing antibiotics as well as nutrients. Details appeared 9 September 2016 in Science (doi:10 .1126/science.aag0822).
The MEGA-plate, which Kishony and his collaborators developed, consists of a 120-by-60-cm dish fılled with agar containing nutrients and different concentrations of antibiotics. Its size enables an antibiotic gradient to be maintained for about 10 days, allowing drug-sensitive Escherichia coli cells to grow, evolve, and generate suffıcient numbers of mutations to withstand and migrate into higher and higher concentrations of the specifıc antibiotic to which they are being exposed.
For example, an early set of MEGAplates contained four-step gradients of either trimethoprim or ciprofloxacin. E. coli cells were inoculated onto drugfree regions of plates and allowed to spread. When the inoculant cells reached antibiotic concentrations at which they could no longer grow, resistant mutants emerged and their descendants migrated successively into regions containing stepped-up concentrations of one or the other of the two antibiotics.
"Importantly, access to intermediate regions of moderate selection enables a range of evolutionary pathways to high-level resistance," Kishony says. When bacteria were inoculated onto variant MEGA-plates in which they were challenged to go directly from nodrug to high-drug areas, they were unable to adapt. By moving through regions of escalating antibiotic intensity, the E. coli ultimately developed high levels of resistance, but it invariably came at the expense of growth rate. Although subsequent mutations compensated, in the absence of suffıcient nutrients these very fıt mutants became trapped.
"Thus, even though more fıt, the bacteria with compensatory mutations were usually spatially restricted from contributing to the ultimate evolutionary success of the population," says Michael Baym at Harvard Medical School, the project's lead scientist. "The fıtness of a bacterial population confronted by increasing antibiotic levels in natural and clinical setting is not driven by the fıttest bacteria but rather by those that are both suffıciently fıt and suffıciently close to the advancing front," adds his colleague Tami Lieberman, also at Harvard Medical School.
These experiments have really captivated people-scientists and regular folks alike-not only because they let people see evolution as it happens, but also because the "fılms they took of bacteria evolving are just plain cool to watch," says James Jeffrey Morris at the University of Alabama at Birmingham, adding: "This isn't the Kishony lab's fırst 'gee whiz' experiment." And says Harmit Malik from the Fred Hutchinson Cancer Research Center in Seattle, Washington, there is "amazing value watching evolution in action for students: just like a chemical reaction taking place, seeing is believing."
Marcia Stone is a science journalist based in New York City. Some bacteria use metals such as arsenic and iron instead of oxygen in electron-transfer reactions that are necessary for their metabolism. Indeed, some ancient bacteria depended on iron rather than water for a form of photosynthe-
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Microbe-Volume 11, Number 12, 2016 • 419 CURRENT TOPICS sis, consistent with this type of anoxygenic metabolism catalyzing deposition of early banded-iron geologic formations, according to Newman and her collaborators. They also are studying the pathogen Pseudomonas aeruginosa, which can use electron-shuttling phenazines as a means for surviving within lungs.
Similar to Newman, Orphan studies microorganisms in places where oxygen is scarce-in this case, deep-sea beds. Some of these microbes depend on anaerobic oxidation of methane, a process that helps to prevent this greenhouse gas, which is being released from underwater seeps, from reaching the atmosphere. Another line of her research focuses on an oxidative, extracellular electron transfer process that couples methane-consuming archaea with sulfate-reducing bacteria.
Among other projects, Prakash recently invented several "frugal science" devices that may prove useful for diagnosing infectious diseases in fıeld settings. For example, he incorporated an origamibased folding design into a lightweight optical microscope that is being fıeld-tested for use in public health and biomedical settings. Meanwhile, a specialized microfluidic chip is being developed to collect nanoliter-scale samples of saliva from mosquito bites to screen for pathogens. Such a device might be used, for example, to collect surveillance data during mosquitoborne disease outbreaks such as the one now involving the Zika virus.
Finally 
